ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
41
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,545
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Combination lipid therapy in type 2 diabetes.
Author(s):
Hannah V Carey
,
Jean-Charles Fruchart
,
F Sacks
Publication date:
2010-08-12
Journal:
The New England journal of medicine
Keywords:
Cholesterol, HDL
,
blood
,
Coronary Disease
,
prevention & control
,
Diabetes Mellitus, Type 2
,
complications
,
drug therapy
,
Drug Therapy, Combination
,
Dyslipidemias
,
Fenofibrate
,
therapeutic use
,
Humans
,
Hypolipidemic Agents
,
Odds Ratio
,
Triglycerides
Read this article at
ScienceOpen
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Drug_transporters
Author and article information
Journal
PubMed ID::
20842772
ScienceOpen disciplines:
Chemistry
Keywords:
Cholesterol, HDL
,
blood
,
Coronary Disease
,
prevention & control
,
Diabetes Mellitus, Type 2
,
complications
,
drug therapy
,
Drug Therapy, Combination
,
Dyslipidemias
,
Fenofibrate
,
therapeutic use
,
Humans
,
Hypolipidemic Agents
,
Odds Ratio
,
Triglycerides
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Cholesterol, HDL
,
blood
,
Coronary Disease
,
prevention & control
,
Diabetes Mellitus, Type 2
,
complications
,
drug therapy
,
Drug Therapy, Combination
,
Dyslipidemias
,
Fenofibrate
,
therapeutic use
,
Humans
,
Hypolipidemic Agents
,
Odds Ratio
,
Triglycerides
Comments
Comment on this article
Sign in to comment
Similar content
1,545
Self-Care Behaviors and Glycemic Control in Low-Income Adults in México With Type 2 Diabetes Mellitus May Have Implications for Patients of Mexican Heritage Living in the United States.
Authors:
Lidia G Compeán Ortiz
,
Beatriz Del Ángel Pérez
,
Eunice Reséndiz González
…
Effects of aerobic exercise intensity on 24-h ambulatory blood pressure in individuals with type 2 diabetes and prehypertension
Authors:
Pâmella Karoline de Morais
,
Marcelo Magalhães Sales
,
Jeeser Almeida
…
Engaging primary care professionals in collaborative processes for optimising type 2 diabetes prevention practice: the PREDIAPS cluster randomised type II hybrid implementation trial
Authors:
Alvaro I Sánchez
,
Gonzalo Grandes
,
Susana Pablo
…
See all similar
Cited by
40
Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017
Authors:
Tânia Martinez
,
Tales de Carvalho
,
Roberto Betti
…
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
Authors:
M. John Chapman
,
Henry N Ginsberg
,
Pierre Amarenco
…
2018 Guidelines for the management of dyslipidemia
Authors:
Eun-Jung Rhee
,
Hyeon Chang Kim
,
Jae Kim
…
See all cited by